Skip to main content
. 2014 Oct 8;2:18. doi: 10.1186/2050-7771-2-18

Table 2.

Patient characteristics and distributions of IDH mutations for all patients and within groups

CHARACTERISTIC
All
IDH1 codon 132:
IDH1 codon 105 (synonymous SNP):
IDH2 codon 140:
IDH2 codon 172:
Total n = 189   Wild type Mutation Wild type Variant Wild type Mutation Wild type Mutation
Age median (range), years
64 (19–88)
63 (19–85)
70 (30–88)*
64 (19–88)
66 (29–84)
63 (19–88)
66 (37–83)*
64 (19–88)
72 (46–74)*
Gender
 
 
 
 
 
 
 
 
 
      Male
95
90
5
85
10
85
10
92
3
      Female
94
84
10
84
10
83
11
92
2
Karyotype
 
 
 
 
 
 
 
 
 
      Normal
108
99
9
95
13
96
12
106
2
      Aberrant
75
69
6
68
7
66
9
72
3
      Missing data
6
6
 
6
 
6
 
6
 
Risk group
 
 
 
 
 
 
 
 
 
      Low
32
31
1
30
2
29
3
31
1
      Intermediate
87
80
7
72
15
75
12
86
1
      High
55
51
4
52
3
51
4
52
3
      Missing data
15
12
3
15
 
13
2
14
1
FLT3 status
 
 
 
 
 
 
 
 
 
      FLT3 wild type
116
109
7
104
12
101
15
114
2
      FLT3-ITD
37
34
3
32
5
33
4
36
1
      Missing data**
36
31
5
33
3
34
2
34
2
      NPM1 status
 
 
 
 
 
 
 
 
 
      NPM1 wild type
99
92
7
87
12
88
11
96
3
      NPM1 mutation
52
49
3
47
5
44
8
52
0
      Missing data**
38
33
5
35
3
36
2
36
2
Induction treatment response
 
 
 
 
 
 
 
 
 
      Complete remission
132
122
10
119
13
119
13
127
5
      Not complete remission
49
44
5
43
6
43
6
49
0
      Missing information
8
8
0
7
1
6
2
8
0
IDH1 codon 132
 
 
 
 
 
 
 
 
 
      Wild type
174
 
 
157
17
153
21
169
5
      Mutation
15
 
 
12
3
15
0
15
0
IDH1 codon 105 (synonymous SNP)
 
 
 
 
 
 
 
 
 
      Wild type
169
 
 
 
 
151
18
165
5
      Variant
20
 
 
 
 
17
3
19
1
IDH2 codon 140
 
 
 
 
 
 
 
 
 
      Wild type
168
 
 
 
 
 
 
163
5
      Mutation
21
 
 
 
 
 
 
21
0
IDH2 codon 172
 
 
 
 
 
 
 
 
 
      Wild type
184
 
 
 
 
 
 
 
 
      Mutation 5                

*Mann–Whitney test for difference in age distribution between patients with IDH mutation (IDH1 or IDH2) and IDH wildtype patients, median 62 vs 69 years; p = 0.036.

**FLT3-ITD and NPM1 mutations were not routinely analyzed in all non-normal karyotype patients.